HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members
Why a doctor should
Username/Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

MAXIJUL overview
Super Soluble Maxijul and Liquid Maxijul: Disease related Maxijul: Disease related malnutrition, malabsorption states or other conditions requiring fortification with a high or readily available carbohydrate supplement. Maxijul LE: As Super Soluble but where sodium and/or potassium restriction is essential.
Discovery explains why H1N1 virus cannot spread as effectively as seasonal flu
Researchers from the Massachusetts Institute of Technology, US, have revealed why the...
Published Friday 03 July 2009

Gene expressions may help understanding of JIA, experts say
Scientists working at the National Institute of Arthritis and Musculoskeletal and Skin...
Published Friday 03 July 2009

Smoking can trigger migraines, Spanish study concludes
Smokers are more likely to suffer from migraine attacks than people who...
Published Friday 03 July 2009

Mice could hold key to understanding non-motor Parkinson's symptoms
Genetically-modified mice can reproduce many of the non-motor symptoms associated with Parkinson's...
Published Friday 03 July 2009

Poor sleep in women with postnatal depression linked to depression
Postpartum women with insomnia may be more likely to suffer from depression,...
Published Thursday 02 July 2009

Researchers could develop kidney disease treatment following discovery
A new discovery could lead to the improved diagnosis and treatment of...
Published Thursday 02 July 2009

Peptide nanoparticles could offer improved meningitis treatment
Doctors could soon be able to treat bacterial meningitis more effectively thanks...
Published Wednesday 01 July 2009

Treatment combination could benefit hepatitis C patients
Hepatitis C patients could benefit from a new combination of treatments, researchers...
Published Tuesday 30 June 2009

Insomnia is particularly severe among war veterans
War veterans suffering from insomnia and post-deployment adjustment disorders have symptoms as...
Published Tuesday 30 June 2009

Research could pave the way for new arthritis treatments
A new treatment for rheumatoid arthritis could be developed following a discovery...
Published Monday 29 June 2009

Teenagers are using less contraception, study suggests
The progress made in terms of contraceptive use among teenagers has stalled,...
Published Friday 26 June 2009

Enzyme helps to destroy mutated protein associated with Parkinson's
A naturally-occurring enzyme in the brain has been discovered which helps to...
Published Friday 26 June 2009

People who are civically engaged may be less likely to suffer from asthma
Areas with restaurants, cultural hubs and entertainment facilities may have lower rates...
Published Thursday 25 June 2009

Omacetaxine offers hope to CML patients
A new drug being developed by ChemGenex Pharmaceuticals could offer hope to...
Published Wednesday 24 June 2009

GIST patients at heightened risk of further tumours
Gastrointestinal stromal tumour (GIST) patients are at an increased risk of second,...
Published Wednesday 24 June 2009

Cystic fibrosis patients could benefit from new treatment
A new therapy that increases airway hydration could benefit cystic fibrosis patients,...
Published Tuesday 23 June 2009

More Medical News
Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Benign prostatic hyperplasia is a progressive disease defined histologically and characterized by stromal and epithelial cell hyperplasia beginning in the periurethral zone of the prostate. Parkinson's disease (PD) is a degenerative disorder of the central nervous system characterized by the clinically asymmetric onset of resting tremor, bradykinesia, rigidity and postural instability. Calendar of this months Global and European Medical conferences in Healthcare

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: United Kingdom
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Related DrugsDrug Details
MAXIJUL
Drug class Description :

Carbohydrate supplements (Foods (ACBS approved)).

Generic Name :

Carbohydrate

Drug description :

Super Soluble Maxijul: powder. 380 kcal/100 g. Liquid Maxijul: liquid in 4 flavours (natural, blackcurrant, lemon and lime, orange). 200 kcal/100 mL. Maxijul LE: powder. 384 kcal/ 100 g.

Presentation :

Super Soluble Maxijul: Carbohydrate (dried glucose syrup) 95 g, sodium, potassium, chloride, phosphorus per 100 g. Liquid Maxijul: Carbohydrate (dried glucose syrup) 50 g, sodium, potassium, phosphorus per 100 mL. Maxijul LE: Carbohydrate (dried glucose syrup) 96 g, very low levels of sodium, potassium, chloride, phosphorus per 100 g.

Indications :

Super Soluble Maxijul and Liquid Maxijul: Disease related Maxijul: Disease related malnutrition, malabsorption states or other conditions requiring fortification with a high or readily available carbohydrate supplement. Maxijul LE: As Super Soluble but where sodium and/or potassium restriction is essential.

Manufacturer :

SHS

Drug Updated :

01 May 2001

Related Drugs - Modular supplements
New and updated Drugs
UK Drugs EPG News Feed
Spanish Drugs EPG News Feed
German Drugs EPG News Feed
Norweigan Drugs EPG News Feed
Netherlands Drugs EPG News Feed
Swedish Drugs EPG News Feed

TREATMENT IN FOCUS

Cystic Fibrosis

DRUG UPDATES Drug updates feed

CONNECT

EMAIL BULLETINS

DISEASE CENTRES Disease Centres feed

MEDICAL NEWS EPG News Feed

RESEARCH

GOOGLE SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed


Copyright © 1999 - 2009 EPG ONLINE